Saturday 17 October 2026
Export ILMN’s income statement to Excel — free account
Illumina, Inc.
ILMN Healthcare Diagnostics & Research
Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024. In the quarter to June 2026, revenue grew 9.44%, EPS fell 8.05%, free cash flow fell 18.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
262.03
5.90
−2.20%
Follow ILMN
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
23.93 | 0.00 | 0.00 | 0.00 | 72.71 | 80.34 | 47.39 | 51.91 | 43.59 | 40.50 |
Piotroski F-Score |
8 | 5 | 5 | 3 | 3 | 5 | 7 | 5 | 7 | 4 |
P/S ratio |
4.68 | 4.86 | 4.70 | 6.69 | 12.27 | 16.33 | 13.39 | 12.87 | 11.56 | 7.82 |
Altman Z-Score |
4.39 | 3.45 | 3.16 | 2.73 | 8.34 | 13.04 | 12.86 | 10.24 | 9.44 | 7.41 |
P/FCF ratio |
22.19 | 30.05 | 75.27 | 0.00 | 171.33 | 60.26 | 57.22 | 51.49 | 57.64 | 36.93 |
Altman Z″-Score (non-manufacturers) |
3.04 | 0.35 | 1.34 | (0.34) | 4.34 | 7.05 | 7.90 | 6.13 | 6.11 | 5.71 |
Beneish M-Score |
(2.51) | (4.32) | (3.12) | (4.56) | (1.48) | (2.89) | (2.18) | (2.63) | (2.55) | (2.83) |
P/Operating CF |
63.33 | 58.37 | 94.42 | 208.69 | 196.85 | 130.32 | 107.08 | 142.96 | 108.22 | 71.57 |
P/B ratio |
7.47 | 8.95 | 3.68 | 4.65 | 5.17 | 11.27 | 10.28 | 11.15 | 11.57 | 8.26 |
Price to Tangible BV |
14.52 | 22.02 | 102.17 | 409.04 | 147.25 | 14.48 | 13.02 | 15.16 | 17.65 | 14.99 |
EV/Sales |
4.76 | 5.03 | 4.90 | 6.68 | 12.45 | 15.63 | 12.76 | 12.41 | 11.22 | 7.61 |
EV/EBITDA |
19.20 | 0.00 | 0.00 | 0.00 | 352.23 | 62.73 | 37.09 | 37.51 | 38.97 | 24.08 |
EV/Operating CF |
19.16 | 26.29 | 46.18 | 78.10 | 103.41 | 46.87 | 43.02 | 36.23 | 35.27 | 23.43 |
EV/FCF |
22.57 | 31.12 | 78.55 | (402.84) | 173.94 | 57.65 | 54.53 | 49.67 | 55.91 | 35.95 |
Quick Ratio |
1.57 | 1.26 | 1.14 | 0.98 | 1.82 | 3.18 | 6.00 | 2.23 | 3.43 | 2.75 |
Current Ratio |
2.08 | 1.78 | 1.66 | 1.28 | 2.48 | 3.60 | 6.69 | 2.49 | 3.99 | 3.29 |
Net Debt/EBITDA |
(0.13) | (0.56) | (0.68) | 0.15 | 2.23 | (2.84) | (1.83) | (1.37) | (1.20) | (0.66) |
Debt/Assets |
22.43% | 23.64% | 14.73% | 12.14% | 11.14% | 15.61% | 16.21% | 28.70% | 22.67% | 24.71% |
Debt/Equity |
0.55 | 0.63 | 0.26 | 0.23 | 0.16 | 0.25 | 0.26 | 0.52 | 0.43 | 0.47 |
Asset Turnover |
0.67 | 0.53 | 0.40 | 0.33 | 0.40 | 0.43 | 0.50 | 0.55 | 0.58 | 0.60 |
Operating CF/Net income |
1.27 | (0.68) | (0.41) | (0.09) | 0.72 | 1.65 | 1.05 | 1.38 | 1.21 | 1.68 |
Capex/Depreciation |
(0.55) | (0.36) | (0.45) | (1.18) | (0.73) | (0.83) | (0.89) | (1.35) | (1.68) | (1.58) |
Interest Coverage |
7.99 | (8.33) | (13.88) | (160.73) | (2.02) | 11.84 | 18.94 | 15.49 | 16.38 | 17.79 |
| 33.36% | (30.13%) | (18.81%) | (50.80%) | 9.87% | 14.10% | 23.69% | 25.05% | 28.93% | 22.48% | |
| 13.13% | (14.90%) | (10.38%) | (32.07%) | 6.68% | 8.80% | 14.04% | 13.52% | 15.22% | 11.62% | |
ROIC |
19.55% | (19.70%) | (10.81%) | (43.18%) | (0.69%) | 15.07% | 25.81% | 23.69% | 21.09% | 20.74% |
Return on Tangible Assets |
34.51% | (60.72%) | (56.74%) | (234.38%) | 28.82% | 15.77% | 21.43% | 21.96% | 22.94% | 19.91% |
Average Days of Receivables |
71.77 | 61.36 | 59.48 | 53.43 | 52.26 | 54.88 | 59.03 | 56.29 | 54.51 | 57.99 |
Research and Development Expense of Revenue |
22.27% | 26.74% | 30.06% | 28.82% | 26.18% | 21.06% | 18.26% | 18.69% | 19.84% | 21.02% |
Selling, General and Administrative Expense of Revenue |
25.01% | 24.98% | 35.79% | 28.29% | 46.22% | 29.05% | 23.57% | 23.82% | 24.49% | 24.35% |
Intangible Assets out of Total Assets |
0.20 | 0.22 | 0.55 | 0.53 | 0.68 | 0.14 | 0.13 | 0.15 | 0.18 | 0.24 |
Share Based Compensation of Revenue |
6.33% | 8.46% | 8.44% | 7.98% | 16.66% | 5.99% | 5.48% | 5.79% | 5.96% | 5.38% |
Graham Net Nets |
(0.03) | (0.06) | (0.08) | (0.07) | (0.03) | 0.03 | 0.04 | 0.03 | 0.01 | 0.02 |
Graham Number |
46.54 | 0.00 | 0.00 | 0.00 | 90.55 | 56.73 | 69.34 | 57.51 | 46.02 | 33.08 |
Earnings Yield |
4.18% | (5.74%) | (5.48%) | (14.33%) | 1.38% | 1.24% | 2.11% | 1.93% | 2.29% | 2.47% |
Free Cash Flow Yield |
4.51% | 3.33% | 1.33% | (0.25%) | 0.58% | 1.66% | 1.75% | 1.94% | 1.73% | 2.71% |
Revenue per Share |
28.02 | 27.50 | 28.51 | 29.20 | 30.17 | 22.03 | 24.10 | 22.67 | 18.85 | 16.31 |
Operating CF per Share |
6.96 | 5.26 | 3.03 | 2.50 | 3.63 | 7.35 | 7.15 | 7.77 | 5.99 | 5.30 |
Capex per Share |
(0.95) | (0.80) | (1.24) | (2.97) | (1.39) | (1.29) | (1.42) | (2.01) | (2.14) | (1.84) |
Free Cash Flow per Share |
6.01 | 4.46 | 1.78 | (0.47) | 2.25 | 6.06 | 5.73 | 5.76 | 3.86 | 3.46 |
Cash per Share |
10.54 | 7.67 | 6.67 | 12.97 | 8.93 | 23.62 | 23.22 | 23.89 | 14.69 | 10.61 |
Shareholders Equity per Share |
17.57 | 14.92 | 36.36 | 42.03 | 71.60 | 31.93 | 31.38 | 26.16 | 18.83 | 15.44 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
17.57 | 14.92 | 36.36 | 42.03 | 71.60 | 31.93 | 31.38 | 26.16 | 18.83 | 15.44 |
Free Cash Flow |
931.00 | 709.00 | 282.00 | (74.00) | 337.00 | 891.00 | 842.00 | 846.00 | 563.00 | 508.00 |
Working Capital |
1,704.00 | 1,199.00 | 1,039.00 | 788.00 | 1,620.00 | 3,239.00 | 3,786.00 | 2,686.00 | 2,234.00 | 1,613.00 |
Capital Expenditures |
(148.00) | (128.00) | (196.00) | (466.00) | (208.00) | (189.00) | (209.00) | (296.00) | (312.00) | (271.00) |
Net Current Asset Value |
(632.00) | (1,184.00) | (1,757.00) | (2,092.00) | (1,764.00) | 1,592.00 | 1,748.00 | 1,376.00 | 472.00 | 307.00 |
EV/EBIT |
25.62 | 0.00 | 0.00 | 0.00 | 0.00 | 87.28 | 45.90 | 46.86 | 50.93 | 31.09 |
Capex to Sales |
0.03 | 0.03 | 0.04 | 0.10 | 0.05 | 0.06 | 0.06 | 0.09 | 0.11 | 0.11 |
Price to Operating Income |
25.19 | 0.00 | 0.00 | 0.00 | 0.00 | 91.22 | 48.16 | 48.57 | 52.50 | 31.94 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.36 | 0.43 | 0.43 | 0.36 | 0.28 | 0.25 | 0.26 | 0.20 | 0.20 | 0.24 |
Cash ROIC |
15.93% | 13.95% | 3.40% | (0.73%) | 2.45% | 9.53% | 9.14% | 9.04% | 9.25% | 10.39% |
Accounts Receivable Turnover |
5.47 | 5.95 | 6.41 | 6.95 | 7.98 | 6.11 | 6.52 | 7.21 | 6.95 | 6.26 |
Accounts Payable Turnover |
6.39 | 6.49 | 6.54 | 5.16 | 5.24 | 6.08 | 6.46 | 6.01 | 6.21 | 5.28 |
Inventory Turnover |
2.65 | 2.66 | 3.05 | 3.23 | 3.42 | 2.83 | 2.89 | 2.87 | 2.93 | 2.56 |
Average Days of Payables |
59.47 | 53.39 | 50.81 | 66.34 | 88.32 | 67.64 | 50.54 | 65.01 | 63.07 | 68.81 |
Days of Inventory on Hand |
139.76 | 132.13 | 121.74 | 128.61 | 114.66 | 131.06 | 121.78 | 136.39 | 131.26 | 149.59 |
Average Receivables |
794.50 | 734.50 | 702.50 | 659.50 | 567.50 | 530.00 | 543.50 | 462.50 | 396.00 | 383.26 |
Average Payables |
230.50 | 233.00 | 269.00 | 312.50 | 262.00 | 170.50 | 166.50 | 172.00 | 149.00 | 138.61 |
Average Inventory |
555.50 | 567.00 | 577.50 | 499.50 | 401.50 | 365.50 | 372.50 | 359.50 | 316.50 | 285.39 |
Average Assets |
6,473.50 | 8,207.00 | 11,181.50 | 13,734.50 | 11,401.00 | 7,450.50 | 7,137.50 | 6,108.00 | 4,769.00 | 3,984.37 |
Average Common Equity |
2,548.00 | 4,059.00 | 6,172.00 | 8,669.50 | 7,717.00 | 4,653.50 | 4,229.00 | 3,297.00 | 2,509.50 | 2,059.28 |
Columns are period end dates